NCT07349771 2026-01-20Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS TrialMayo ClinicPhase 2 Not yet recruiting72 enrolled
NCT07302776 2025-12-24TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTStanford UniversityPhase 1 Not yet recruiting50 enrolled
NCT06996119 2025-05-30Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantCity of Hope Medical CenterPhase 1 Not yet recruiting15 enrolled